Oncotelic Therapeutics, Inc. (OTLC) Financials
OTLC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 394.0 trillion | 131.7 trillion |
| Dec. 31, 2025 | 393.1 trillion | 131.4 trillion |
| Sept. 30, 2025 | 28.2 million | 20.1 million |
| June 30, 2025 | 26.7 million | 19.3 million |
OTLC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -342.2 billion | 1.6 trillion |
| Dec. 31, 2025 | -783020 | 2.4 trillion |
| Sept. 30, 2025 | -307027 | 183742 |
| June 30, 2025 | -126151 | ? |
OTLC Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| March 31, 2026 | -2.2 trillion |
| Dec. 31, 2025 | 249.0 trillion |
| Sept. 30, 2025 | -1.2 million |
| June 30, 2025 | 210449 |
OTLC Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 63.6 billion | - | - |
| Dec. 31, 2025 | 88.9 billion | - | - |
| Sept. 30, 2025 | 409000 | - | - |
| June 30, 2025 | 88022 | - | - |
OTLC Shares Outstanding
OTLC Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 3 | 795.0 million | 1.9 trillion | - |
| Dec. 31, 2025 | 3 | 4.4 billion | 3.2 trillion | - |
| Sept. 30, 2025 | 5 | 426 | 490547 | - |
| June 30, 2025 | - | 297 | 65672 | - |
OTLC Cost of Revenue
No data available :(
OTLC
Price: $0.04
52 week price:
Earnings Per Share: -0.01 USD
P/E Ratio: -4
Exchange: OQB
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 17.7 million